Skip to main content
. 2023 Apr 16;132:34–39. doi: 10.1016/j.ijid.2023.04.396

Figure 1.

Figure 1

Maximum respiratory support by monoclonal antibody treatment status among patients hospitalized within 28 days within the propensity-matched cohort. Comparing severity of hospitalizations for bebtelovimab-treated (n = 48) and untreated patients (n = 116), the maximum level of respiratory support appeared lower for bebtelovimab-treated patients, but inferential statistics were not able to be performed. Abbreviations: HFNC, high-flow nasal cannula oxygen; IMV, invasive mechanical ventilation; NIV, noninvasive ventilation.